ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma

Shen Gang; Rong Xiaoxiang; Zhao Jianbo; Yang Xuewei; Li Haibo; Jiang Hua; Zhou Qiang; Ji Tianxing; Huang Sicong; Zhang Jing; Jia Hongyun*广州医学院; 南方医科大学
Carcinogenesis2014-12DOI: 10.1093/carcin/bgu208
10被引8阅读
引用收藏
分享

摘要

A growing amount of evidence supports that microRNA (miRNA) dysregulation is involved in cancer progression by directly downregulating multiple targets. Elucidating the underlying mechanism of miRNA in carcinogenesis may improve diagnostic and therapeutic strategies for malignancy. In the current study, we found that miR-105 expression was markedly downregulated in both hepatocellular carcinoma (HCC) cell lines and clinical HCC tissues, compared with normal human hepatocyte and adjacent non-cancerous tissues, respectively. Ectopic miR-105 expression suppressed, whereas inhibiting miR-105 promoted the proliferation and tumorigenicity of HCC cells both in vitro and in vivo. Furthermore, we demonstrated that miR-105 could deactivated the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway by downregulating insulin receptor substrate-1, 3-phosphoinositide-dependent protein kinase-1 and AKT1 directly, resulting in increasing cyclin-dependent kinase inhibitors 1A and 1B (p21Cip1 and p27Kip1) and decreasing cyclin D1 expression in HCC. Therefore, our results suggest that miR-105 functions as a potential tumor suppressor by inhibiting the PI3K/AKT signaling pathway and might represent a potential therapeutic target for HCC patients.

相关
加载中…
  • MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4)
    Xue Jing; Chen Li Zhang*; Li Zhan Zhan; Hu Ying yun; Yan Shi peng; Liu Li YaMolecular and Cellular Biochemistry, 2015, 399(1-2): 77-86.
  • Up-regulation of miR-19a in hepatocellular carcinoma and regulation of biological function of hepatocellular carcinoma cells by targeting PTEN
    Ji, Manru; Nie, Wenbao; An, Hongjun; Fu, Zhongze; Liu, Xia; Shi, Yanhui; Zhao, Dongmei; Xu, Jing
  • Little things with significant impact: miRNAs in hepatocellular carcinoma
    Li, Jiehan; Bao, Haolin; Huang, Ziyue; Liang, Zixin; Wang, Mei; Lin, Ning; Ni, Chunjie; Xu, Yi*Frontiers in Oncology, 2023, 13: 1191070.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Carcinogenesis
发表日期
2014-12
卷期
第 35 卷, 第 12 期
页码
2748-2755
DOI
10.1093/carcin/bgu208
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q1
成果收录
SCI
资助标注
National Science Foundation of China [81101317]; Science and Technology Planning Project of Guangdong Province, China [2012B010200027]; Science and Technology Department of Guangzhou [2014J4100063]

作者

  • S

    Shen Gang (第一作者)

  • R

    Rong Xiaoxiang

    southern med univ

查看全部 11 位作者收起作者
  • Z

    Zhao Jianbo

    southern med univ

  • Y

    Yang Xuewei

    guangzhou med univ

  • L

    Li Haibo

    guangzhou med univ

  • J

    Jiang Hua

    guangzhou med univ

  • Z

    Zhou Qiang

    guangzhou med univ

  • J

    Ji Tianxing

    guangzhou med univ

  • H

    Huang Sicong

    guangzhou med univ

  • Z

    Zhang Jing

    guangzhou med univ

  • J

    Jia Hongyun (通讯)

    guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417